Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Nuclera
company
About
Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $15.50M
- Industries
- Biotechnology,Industrial Engineering,Life Science,Pharmaceutical
- Founded date
- Aug 27, 2013
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered to take control of biology through streamlined access to a next-day supply of proteins and genes.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$58M
Nuclera has raised a total of
$58M
in funding over 2 rounds. Their latest funding was raised on
Jul 6, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 6, 2022 | Series B | $15.50M | 1 |
Verve Ventures
|
— | Detail |
| Feb 2, 2022 | Series B | $42.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Nuclera is funded by 2 investors.
Verve Ventures
and RT Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Verve Ventures
|
Yes | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
